arrow
Back
E

Edward Gane

university of auckland

97H-index
726Paper Count
5.7WCitation Count
Published Papers 361
Publication Date
errShare
errSave
Safety, Tolerability, and Pharmacodynamics of GS-4224 in Healthy Participants and Participants With Chronic Hepatitis B
err2026-05-21
err0
PREAI
errEdward J. Gane; Chi-Yi Chen; Cheng-Hao Tseng; Chun-Yen Lin; Stuart K. Roberts; Dana Tedesco; Frida Abramov; Fangqiu Zhang; Jared M. Odegard; Jeffrey J. Wallin; Naveed A. Shaik; Teri Chew; Latesh Lad; Adele Y. Wang; Scott Balsitis; Simon P. Fletcher; Audrey H. Lau; Wan-Long Chuang; Kosh Agarwal
errShare
errSave
A plain language summary of the CheckMate 9DW study: nivolumab in combination with ipilimumab for unresectable hepatocellular carcinoma (advanced liver cancer)
err2026-04-14
err0
PREAI
errThomas Yau; Peter R Galle; Thomas Decaens; Bruno Sangro; Shukui Qin; Leonardo G da Fonseca; Hatim Karachiwala; Jean-Frederic Blanc; Joong-Won Park; Edward Gane; Matthias Pinter; Ana Matilla Peña; Masafumi Ikeda; David Tai; Armando Santoro; Gonzalo Pizarro; Chang-Fang Chiu; Michael Schenker; Aiwu He; Hong Jae Chon; Joanna Wojcik-Tomaszewska; Gontran Verset; Qi Qi Wang; Caitlyn Stromko; Jaclyn Neely; Prianka Singh; Maria Jesus Jimenez Exposito; Masatoshi Kudo
errShare
errSave
An oral, liver-restricted LXR inverse agonist for dyslipidemia: preclinical development and phase 1 trial
err2026-01-16
err0
errOAAI
errXiaoxu Li; Giorgia Benegiamo; Archana Vijayakumar; Natalie Sroda; Masaki Kimura; Ryan S. Huss; Steve Weng; Eisuke Murakami; Brian J. Kirby; Giacomo V. G. von Alvensleben; Claus Kremoser; Edward J. Gane; Takanori Takebe; Robert P. Myers; G. Mani Subramanian; Johan Auwerx
errShare
errSave
Corrigendum to “Peginterferon-alpha-2a add-on to treatment with siRNA JNJ-73763989 in virologically suppressed chronic hepatitis B: The phase II PENGUIN study” [JHEP Reports 2025 7(10) 101516]
err2025-11-24
err0
errOAAI
errEdward Gane; Ewa Janczewska; Tetsuo Takehara; Wan-Long Chuang; Cheng-Yuan Peng; Maria Hlebowicz; Yasuhiro Asahina; Ting-Tsung Chang; Ronald Kalmeijer; John Jezorwski; Gloria Kim; Zacharias Anastasiou; Thomas N. Kakuda; Thierry Verbinnen; Nonko Pehlivanov; Adam Bakala; Oliver Lenz; Michael Biermer
errShare
errSave
A Phase 2 Trial of Tobevibart plus Elebsiran in Hepatitis D
err2025-11-01
err2
PREAI
errAsselah, Tarik; Chattergoon, Michael A.; Jucov, Alina; Streinu-Cercel, Anca; Lampertico, Pietro; Wedemeyer, Heiner; Kennedy, Patrick T.; Gane, Edward J.; Bullard, Brianna L.; Chow, Sophia; Santos, Desiree; Camus, Gregory; Lu, Yimeng; Pilowa, Cara; Hwang, Carey; Correll, Todd; Agarwal, Kosh
errShare
errSave
Safety and efficacy of tenofovir alafenamide in preventing hepatitis B virus recurrence after liver transplantation in patients with chronic kidney disease maintained on tenofovir disoproxil fumarate: results from a phase 2 randomized trial
err2025-09-17
err0
PREAI
errEdward J. Gane; Rica Dagooc; Dominic Ray-Chaudhuri; Vithika Suri; Frida Abramov; Curtis D. Holt; Hongyuan Wang; Catherine Frenette; Anu O. Osinusi; John F. Flaherty
errShare
errSave
Efficacy and Safety of Tenofovir Alafenamide (TAF) and Tenofovir Disoproxil Fumarate (TDF) Followed by TAF in Chronic Hepatitis B Patients of East Asian Ethnicity Following 5 Years of Treatment
err2025-08-12
err0
errOAAI
errGrace Lai-Hung Wong; Edward Gane; Calvin Q. Pan; Scott Fung; Mang M. Ma; Namiki Izumi; Shalimar; Seng Gee Lim; Wan-Long Chuang; Rajiv Mehta; Young-Suk Lim; Leland J. Yee; John F. Flaherty; Frida Abramov; Hongyuan Wang; Maria Buti
errShare
errSave
Peginterferon-alpha-2a add-on to treatment with siRNA JNJ-73763989 in virologically suppressed chronic hepatitis B: the phase 2 PENGUIN study
err2025-07-09
err0
errOAAI
errEdward Gane; Ewa Janczewska; Tetsuo Takehara; Wan-Long Chuang; Cheng-Yuan Peng; Maria Hlebowicz; Yasuhiro Asahina; Ting-Tsung Chang; Ronald Kalmeijer; John Jezorwski; Gloria Kim; Zacharias Anastasiou; Thomas N. Kakuda; Thierry Verbinnen; Nonko Pehlivanov; Adam Bakala; Oliver Lenz; Michael Biermer
errShare
errSave
VIR-2218 (elebsiran) plus pegylated interferon-alfa-2a in participants with chronic hepatitis B virus infection: a phase 2 study
err2024-12-01
err3
PREAI
errYuen, Man-Fung; Lim, Young-Suk; Yoon, Ki Tae; Lim, Tien-Huey; Heo, Jeong; Tangkijvanich, Pisit; Tak, Won Young; Thanawala, Vaidehi; Cloutier, Daniel; Mao, Shenghua; Arizpe, Andre; Cathcart, Andrea L.; Gupta, Sneha, V; Hwang, Carey; Gane, Edward
errShare
errSave
Efficacy, tolerability and pharmacokinetics of survodutide, aglucagon/glucagon-like peptide-1 receptor dual agonist,in cirrhosis
err2024-11-01
err6
errOAAI
errLawitz, Eric J.; Fraessdorf, Mandy; Neff, Guy W.; Schattenberg, Joern M.; Noureddin, Mazen; Alkhouri, Naim; Schmid, Bernhard; Andrews, Charles P.; Takacs, Istvan; Hussain, Samina Ajaz; Fenske, Wiebke K.; Gane, Edward J.; Hosseini-Tabatabaei, Azadeh; Sanyal, Arun J.; Mazo, Daniel F.; Younes, Ramy
errShare
errSave
Eight-year efficacy and safety of tenofovir alafenamide for treatment of chronic hepatitis B virus infection: Final results from two randomised phase 3 trials
err2024-09-27
err2
errOAAI
errButi, Maria; Lim, Young-Suk; Chan, Henry Lik Yuen; Agarwal, Kosh; Marcellin, Patrick; Brunetto, Maurizia R.; Chuang, Wan-Long; Janssen, Harry L. A.; Fung, Scott K.; Izumi, Namiki; Jablkowski, Maciej S.; Abdurakhmanov, Dzhamal; Abramov, Frida; Wang, Hongyuan; Botros, Irina; Yee, Leland J.; Mateo, Roberto; Flaherty, John F.; Osinusi, Anu; Pan, Calvin Q.; Shalimar, X.; Seto, Wai-Kay; Gane, Edward J.
errShare
errSave
Safety, PK, and Preliminary Efficacy of the Liver-Targeted Mitochondrial Protonophore TLC-6740-A Phase 1 Study
err2024-06-14
err0
PREAI
errGane, Edward; Huss, Ryan S.; Sur, Jane; Murakami, Eisuke; Weng, Steve; Kirby, Brian J.; Shah, Amrik; Shulman, Gerald I.; Subramanian, Mani; Vijayakumar, Archana; Myers, Robert P.
errShare
errSave
Personalized neoantigen vaccine and pembrolizumab in advanced hepatocellular carcinoma: a phase 1/2 trial
err2024-04-07
err18
errOAAI
errYarchoan, Mark; Gane, Edward J.; Marron, Thomas U.; Perales-Linares, Renzo; Yan, Jian; Cooch, Neil; Shu, Daniel H.; Fertig, Elana J.; Kagohara, Luciane T.; Bartha, Gabor; Northcott, Josette; Lyle, John; Rochestie, Sarah; Peters, Joann; Connor, Jason T.; Jaffee, Elizabeth M.; Csiki, Ildiko; Weiner, David B.; Perales-Puchalt, Alfredo; Sardesai, Niranjan Y.
errShare
errSave
Cabozantinib plus atezolizumab versus sorafenib for advanced hepatocellular carcinoma (COSMIC-312): final results of a randomised phase 3 study
err2024-04-01
err19
PREAI
errYau, Thomas; Kaseb, Ahmed; Cheng, Ann-Lii; Qin, Shukui; Zhu, Andrew X.; Chan, Stephen L.; Melkadze, Tamar; Sukeepaisarnjaroen, Wattana; Breder, Valery; Verset, Gontran; Gane, Edward; Borbath, Ivan; Rangel, Jose David Gomez; Ryoo, Baek-Yeol; Makharadze, Tamta; Merle, Philippe; Benzaghou, Fawzi; Milwee, Steven; Wang, Zhong; Curran, Dominic; Kelley, Robin Kate; Rimassa, Lorenza
errShare
errSave
Long-term open-label vebicorvir for chronic HBV infection: Safety and off-treatment responses
err2024-04-01
err1
errOAAI
errYuen, Man-Fung; Fung, Scott; Ma, Xiaoli; Nguyen, Tuan T.; Hassanein, Tarek; Hann, Hie -Won; Elkhashab, Magdy; Nahass, Ronald G.; Park, James S.; Jacobson, Ira M.; Ayoub, Walid S.; Han, Steven -Huy; Gane, Edward J.; Zomorodi, Katie; Yan, Ran; Ma, Julie; Knox, Steven J.; Stamm, Luisa M.; Bonacini, Maurizio; Weilert, Frank; Ramji, Alnoor; Bennett, Michael; Ravendhran, Natarajan; Chan, Sing; Dieterich, Douglas T.; Kwo, Paul Yien; Schiff, Eugene R.; Bae, Ho S.; Lalezari, Jacob; Agarwal, Kosh; Sulkowski, Mark S.
errShare
errSave
Efficacy, safety, and pharmacokinetics of capsid assembly modulator linvencorvir plus standard of care in chronic hepatitis B patients
err2024-04-01
err2
errOAAI
errHou, Jinlin; Gane, Edward; Balabanska, Rozalina; Zhang, Wenhong; Zhang, Jiming; Lim, Tien Huey; Xie, Qing; Yeh, Chau-Ting; Yang, Sheng-Shun; Liang, Xieer; Komolmit, Piyawat; Leerapun, Apinya; Xue, Zenghui; Chen, Ethan; Zhang, Yuchen; Xie, Qiaoqiao; Chang, Ting-Tsung; Hu, Tsung-Hui; Lim, Seng Gee; Chuang, Wan -Long; Leggett, Barbara; Bo, Qingyan; Zhou, Xue; Triyatni, Miriam; Zhang, Wen; Yuen, Man-Fung
errShare
errSave
Personalized neoantigen DNA vaccine GNOS-PV02 and pembrolizumab as second-line treatment for advanced hepatocellular carcinoma
err2024-03-22
err0
PREAI
errYarchoan, Mark; Gane, Edward J.; Marron, Thomas U.; Perales-Linares, Renzo; Yan, Jian; Cooch, Neil; Shu, Daniel; Fertig, Elana J.; Kagohara, Luciane T.; Bartha, Gabor; Northcott, Josette; Lyle, John; Rochestie, Sarah; Peters, Joann; Connor, Jason; Jaffee, Elizabeth; Perales-Puchalt, Alfredo; Weiner, David B.; Csiki, Ildiko; Sardesai, Niranjan Y.
errShare
errSave
Detection of circulating tumor DNA predicts survival in advanced HCC patients treated with personalized therapeutic DNA cancer vaccine in combination with immune checkpoint blockade
err2024-03-22
err0
PREAI
errYan, Jian; Li, Bailiang; Northcott, Josette; Abbott, Charles W.; Pyke, Rachel M.; Perales-Linares, Renzo; Cooch, Neil; Rochestie, Sarah; Peters, Joann; Gane, Edward J.; Yarchoan, Mark; Marron, Thomas U.; Boyle, Sean M.; Csiki, Ildiko; Chen, Richard; Sardesai, Niranjan Y.
errShare
errSave